Portola Pharma drug reverses effect of anti-clotting drugs in study

(Reuters) - Portola Pharmaceuticals Inc said its drug met the main goal of reversing the effect of anti-coagulant drugs in a late-stage study. Data showed that an intravenous shot of the drug, andexanet alfa, immediately reversed the effect of Eliquis, an anti-clotting drug by Bristol-Myers Squibb Co and Pfizer Inc. Andexanet alfa is also being tested against Xarelto, a drug made by Bayer Healthcare and Johnson & Johnson's unit Janssen, Portola said in a statement. (Reporting by Vidya L Nathan in Bangalore; Editing by Kirti Pandey)



via Health News Headlines - Yahoo News http://ift.tt/1vx0Cgs